200 related articles for article (PubMed ID: 32610693)
1. Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
Szpak-Ulczok S; Pfeifer A; Rusinek D; Oczko-Wojciechowska M; Kowalska M; Tyszkiewicz T; Cieslicka M; Handkiewicz-Junak D; Fujarewicz K; Lange D; Chmielik E; Zembala-Nozynska E; Student S; Kotecka-Blicharz A; Kluczewska-Galka A; Jarzab B; Czarniecka A; Jarzab M; Krajewska J
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610693
[TBL] [Abstract][Full Text] [Related]
2. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis.
Cerutti JM; Oler G; Michaluart P; Delcelo R; Beaty RM; Shoemaker J; Riggins GJ
Cancer Res; 2007 Aug; 67(16):7885-92. PubMed ID: 17699795
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma.
Reyes I; Reyes N; Suriano R; Iacob C; Suslina N; Policastro A; Moscatello A; Schantz S; Tiwari RK; Geliebter J
Cancer Biomark; 2019; 24(1):71-83. PubMed ID: 30614796
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q
J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract][Full Text] [Related]
7. Identifying the tumor-progressive gene expression profile in high-risk papillary thyroid cancer.
Shibata M; Inaishi T; Ichikawa T; Shimizu D; Soeda I; Takano Y; Takeuchi D; Tsunoda N; Kikumori T
Surg Today; 2021 Oct; 51(10):1703-1712. PubMed ID: 33733290
[TBL] [Abstract][Full Text] [Related]
8. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
9. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D
J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160
[TBL] [Abstract][Full Text] [Related]
10. Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.
Lan X; Bao H; Ge X; Cao J; Fan X; Zhang Q; Liu K; Zhang X; Tan Z; Zheng C; Wang A; Chen C; Zhu X; Wang J; Xu J; Zhu X; Wu X; Wang X; Shao Y; Ge M
Cancer Sci; 2020 Jun; 111(6):2163-2173. PubMed ID: 32187423
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
Hosseinkhan N; Honardoost M; Blighe K; Moore CBT; Khamseh ME
J Endocrinol Invest; 2020 Jul; 43(7):911-923. PubMed ID: 31965517
[TBL] [Abstract][Full Text] [Related]
12. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
[TBL] [Abstract][Full Text] [Related]
13. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma.
Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD
Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.
Fisher KE; Jani JC; Fisher SB; Foulks C; Hill CE; Weber CJ; Cohen C; Sharma J
J Surg Res; 2013 Nov; 185(1):217-24. PubMed ID: 23746767
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
16. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy.
Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR
Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
18. BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.
Rusinek D; Swierniak M; Chmielik E; Kowal M; Kowalska M; Cyplinska R; Czarniecka A; Piglowski W; Korfanty J; Chekan M; Krajewska J; Szpak-Ulczok S; Jarzab M; Widlak W; Jarzab B
PLoS One; 2015; 10(12):e0143688. PubMed ID: 26625260
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.
Oler G; Camacho CP; Hojaij FC; Michaluart P; Riggins GJ; Cerutti JM
Clin Cancer Res; 2008 Aug; 14(15):4735-42. PubMed ID: 18676742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
